Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06971146

Nurse-Led Telehealth for Gout

Led by University of Aarhus · Updated on 2025-09-18

200

Participants Needed

5

Research Sites

95 weeks

Total Duration

On this page

Sponsors

U

University of Aarhus

Lead Sponsor

A

Aarhus University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this clinical trial is to evaluate whether nurse-led telehealth support helps individuals with gout better manage their condition and adhere to urate-lowering medication after discharge from a rheumatology clinic. Eligible patients will be recruited from five rheumatology departments in the Central Denmark Region after achieving two consecutive target serum urate levels-below 0.36 mmol/L, or below 0.30 mmol/L for patients with tophi. Participants will be adults with gout who meet specific medical criteria, are taking medications such as allopurinol or Adenuric, and are able to read and write Danish. Participants will be randomly assigned to one of two groups: * Intervention group: nurse-led telehealth support. * Control group: usual care with follow-up by their general practitioner. The primary goal is to support patients in maintaining healthy uric acid levels after 52 weeks. Participants in the nurse-led group have the option to choose from four support options: I1: App-Based Support - an app provides information and reminders. I2: Letter Reminders - messages are sent via digital or postal mail. I3: Text Reminders - SMS messages are sent every three months. I4: Phone Support - nurses call three times a year to check in.

CONDITIONS

Official Title

Nurse-Led Telehealth for Gout

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Meets the ACR/EULAR 2015 Gout Classification Criteria
  • Estimated Glomerular Filtration Rate (e-GFR) greater than 30 ml/min
  • Prescribed allopurinol or Adenuric and achieved two consecutive serum urate levels at or below 0.30 mmol/L for patients with tophi, or at or below 0.36 mmol/L for patients without tophi
  • Able to read and write Danish well enough to understand information and complete questionnaires
Not Eligible

You will not qualify if you...

  • Cognitive impairment preventing understanding or informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

2

Gødstrup Hospital

Herning, Denmark, 7400

Actively Recruiting

3

Horsens Hospital

Horsens, Denmark, 8700

Actively Recruiting

4

Randers Hospital

Randers, Denmark, 8930

Actively Recruiting

5

Silkeborg Hospital

Silkeborg, Denmark, 8600

Actively Recruiting

Loading map...

Research Team

A

Annette de Thurah, CNS, MPH, PHD

CONTACT

S

Sofie B Vestergaard, RN, MSc, PhD-fellow

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here